Global Opioids Drug Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Opioids Drug market size is predicted to grow from US$ 9330 million in 2025 to US$ 8332 million in 2031; it is expected to grow at a CAGR of -1.9% from 2025 to 2031.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
LP Information, Inc. (LPI) ' newest research report, the “Opioids Drug Industry Forecast” looks at past sales and reviews total world Opioids Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Opioids Drug sales for 2025 through 2031. With Opioids Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioids Drug industry.
This Insight Report provides a comprehensive analysis of the global Opioids Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioids Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Opioids Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioids Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioids Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioids Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Opioids Drug market?
What factors are driving Opioids Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioids Drug market opportunities vary by end market size?
How does Opioids Drug break out by Type, by Application?
The global Opioids Drug market size is predicted to grow from US$ 9330 million in 2025 to US$ 8332 million in 2031; it is expected to grow at a CAGR of -1.9% from 2025 to 2031.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
LP Information, Inc. (LPI) ' newest research report, the “Opioids Drug Industry Forecast” looks at past sales and reviews total world Opioids Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Opioids Drug sales for 2025 through 2031. With Opioids Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioids Drug industry.
This Insight Report provides a comprehensive analysis of the global Opioids Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioids Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Opioids Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioids Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioids Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioids Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Oxycodone
- Hydromorphone
- Codeine
- Fentanyl
- Pain Relief
- Anesthesia
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva
- Purdue Pharma
- Mallinckrodt
- Amneal Pharma
- Collegium
- J&J
- Endo
- Pfizer
- INSYS
- Mylan
- Hikma
- Egalet
What is the 10-year outlook for the global Opioids Drug market?
What factors are driving Opioids Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioids Drug market opportunities vary by end market size?
How does Opioids Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioids Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Opioids Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Opioids Drug by Country/Region, 2020, 2024 & 2031
2.2 Opioids Drug Segment by Type
2.2.1 Oxycodone
2.2.2 Hydromorphone
2.2.3 Codeine
2.2.4 Fentanyl
2.3 Opioids Drug Sales by Type
2.3.1 Global Opioids Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Opioids Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Opioids Drug Sale Price by Type (2020-2025)
2.4 Opioids Drug Segment by Application
2.4.1 Pain Relief
2.4.2 Anesthesia
2.4.3 Others
2.5 Opioids Drug Sales by Application
2.5.1 Global Opioids Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Opioids Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Opioids Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Opioids Drug Breakdown Data by Company
3.1.1 Global Opioids Drug Annual Sales by Company (2020-2025)
3.1.2 Global Opioids Drug Sales Market Share by Company (2020-2025)
3.2 Global Opioids Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Opioids Drug Revenue by Company (2020-2025)
3.2.2 Global Opioids Drug Revenue Market Share by Company (2020-2025)
3.3 Global Opioids Drug Sale Price by Company
3.4 Key Manufacturers Opioids Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioids Drug Product Location Distribution
3.4.2 Players Opioids Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OPIOIDS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Opioids Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Opioids Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Opioids Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Opioids Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Opioids Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Opioids Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Opioids Drug Sales Growth
4.4 APAC Opioids Drug Sales Growth
4.5 Europe Opioids Drug Sales Growth
4.6 Middle East & Africa Opioids Drug Sales Growth
5 AMERICAS
5.1 Americas Opioids Drug Sales by Country
5.1.1 Americas Opioids Drug Sales by Country (2020-2025)
5.1.2 Americas Opioids Drug Revenue by Country (2020-2025)
5.2 Americas Opioids Drug Sales by Type (2020-2025)
5.3 Americas Opioids Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioids Drug Sales by Region
6.1.1 APAC Opioids Drug Sales by Region (2020-2025)
6.1.2 APAC Opioids Drug Revenue by Region (2020-2025)
6.2 APAC Opioids Drug Sales by Type (2020-2025)
6.3 APAC Opioids Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioids Drug by Country
7.1.1 Europe Opioids Drug Sales by Country (2020-2025)
7.1.2 Europe Opioids Drug Revenue by Country (2020-2025)
7.2 Europe Opioids Drug Sales by Type (2020-2025)
7.3 Europe Opioids Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioids Drug by Country
8.1.1 Middle East & Africa Opioids Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Opioids Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Opioids Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Opioids Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioids Drug
10.3 Manufacturing Process Analysis of Opioids Drug
10.4 Industry Chain Structure of Opioids Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioids Drug Distributors
11.3 Opioids Drug Customer
12 WORLD FORECAST REVIEW FOR OPIOIDS DRUG BY GEOGRAPHIC REGION
12.1 Global Opioids Drug Market Size Forecast by Region
12.1.1 Global Opioids Drug Forecast by Region (2026-2031)
12.1.2 Global Opioids Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Opioids Drug Forecast by Type (2026-2031)
12.7 Global Opioids Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Opioids Drug Product Portfolios and Specifications
13.1.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Purdue Pharma
13.2.1 Purdue Pharma Company Information
13.2.2 Purdue Pharma Opioids Drug Product Portfolios and Specifications
13.2.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Purdue Pharma Main Business Overview
13.2.5 Purdue Pharma Latest Developments
13.3 Mallinckrodt
13.3.1 Mallinckrodt Company Information
13.3.2 Mallinckrodt Opioids Drug Product Portfolios and Specifications
13.3.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Mallinckrodt Main Business Overview
13.3.5 Mallinckrodt Latest Developments
13.4 Amneal Pharma
13.4.1 Amneal Pharma Company Information
13.4.2 Amneal Pharma Opioids Drug Product Portfolios and Specifications
13.4.3 Amneal Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Amneal Pharma Main Business Overview
13.4.5 Amneal Pharma Latest Developments
13.5 Collegium
13.5.1 Collegium Company Information
13.5.2 Collegium Opioids Drug Product Portfolios and Specifications
13.5.3 Collegium Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Collegium Main Business Overview
13.5.5 Collegium Latest Developments
13.6 J&J
13.6.1 J&J Company Information
13.6.2 J&J Opioids Drug Product Portfolios and Specifications
13.6.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 J&J Main Business Overview
13.6.5 J&J Latest Developments
13.7 Endo
13.7.1 Endo Company Information
13.7.2 Endo Opioids Drug Product Portfolios and Specifications
13.7.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Endo Main Business Overview
13.7.5 Endo Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Opioids Drug Product Portfolios and Specifications
13.8.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 INSYS
13.9.1 INSYS Company Information
13.9.2 INSYS Opioids Drug Product Portfolios and Specifications
13.9.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 INSYS Main Business Overview
13.9.5 INSYS Latest Developments
13.10 Mylan
13.10.1 Mylan Company Information
13.10.2 Mylan Opioids Drug Product Portfolios and Specifications
13.10.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Mylan Main Business Overview
13.10.5 Mylan Latest Developments
13.11 Hikma
13.11.1 Hikma Company Information
13.11.2 Hikma Opioids Drug Product Portfolios and Specifications
13.11.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hikma Main Business Overview
13.11.5 Hikma Latest Developments
13.12 Egalet
13.12.1 Egalet Company Information
13.12.2 Egalet Opioids Drug Product Portfolios and Specifications
13.12.3 Egalet Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Egalet Main Business Overview
13.12.5 Egalet Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioids Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Opioids Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Opioids Drug by Country/Region, 2020, 2024 & 2031
2.2 Opioids Drug Segment by Type
2.2.1 Oxycodone
2.2.2 Hydromorphone
2.2.3 Codeine
2.2.4 Fentanyl
2.3 Opioids Drug Sales by Type
2.3.1 Global Opioids Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Opioids Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Opioids Drug Sale Price by Type (2020-2025)
2.4 Opioids Drug Segment by Application
2.4.1 Pain Relief
2.4.2 Anesthesia
2.4.3 Others
2.5 Opioids Drug Sales by Application
2.5.1 Global Opioids Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Opioids Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Opioids Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Opioids Drug Breakdown Data by Company
3.1.1 Global Opioids Drug Annual Sales by Company (2020-2025)
3.1.2 Global Opioids Drug Sales Market Share by Company (2020-2025)
3.2 Global Opioids Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Opioids Drug Revenue by Company (2020-2025)
3.2.2 Global Opioids Drug Revenue Market Share by Company (2020-2025)
3.3 Global Opioids Drug Sale Price by Company
3.4 Key Manufacturers Opioids Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioids Drug Product Location Distribution
3.4.2 Players Opioids Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OPIOIDS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Opioids Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Opioids Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Opioids Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Opioids Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Opioids Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Opioids Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Opioids Drug Sales Growth
4.4 APAC Opioids Drug Sales Growth
4.5 Europe Opioids Drug Sales Growth
4.6 Middle East & Africa Opioids Drug Sales Growth
5 AMERICAS
5.1 Americas Opioids Drug Sales by Country
5.1.1 Americas Opioids Drug Sales by Country (2020-2025)
5.1.2 Americas Opioids Drug Revenue by Country (2020-2025)
5.2 Americas Opioids Drug Sales by Type (2020-2025)
5.3 Americas Opioids Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioids Drug Sales by Region
6.1.1 APAC Opioids Drug Sales by Region (2020-2025)
6.1.2 APAC Opioids Drug Revenue by Region (2020-2025)
6.2 APAC Opioids Drug Sales by Type (2020-2025)
6.3 APAC Opioids Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioids Drug by Country
7.1.1 Europe Opioids Drug Sales by Country (2020-2025)
7.1.2 Europe Opioids Drug Revenue by Country (2020-2025)
7.2 Europe Opioids Drug Sales by Type (2020-2025)
7.3 Europe Opioids Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioids Drug by Country
8.1.1 Middle East & Africa Opioids Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Opioids Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Opioids Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Opioids Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioids Drug
10.3 Manufacturing Process Analysis of Opioids Drug
10.4 Industry Chain Structure of Opioids Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioids Drug Distributors
11.3 Opioids Drug Customer
12 WORLD FORECAST REVIEW FOR OPIOIDS DRUG BY GEOGRAPHIC REGION
12.1 Global Opioids Drug Market Size Forecast by Region
12.1.1 Global Opioids Drug Forecast by Region (2026-2031)
12.1.2 Global Opioids Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Opioids Drug Forecast by Type (2026-2031)
12.7 Global Opioids Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Opioids Drug Product Portfolios and Specifications
13.1.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Purdue Pharma
13.2.1 Purdue Pharma Company Information
13.2.2 Purdue Pharma Opioids Drug Product Portfolios and Specifications
13.2.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Purdue Pharma Main Business Overview
13.2.5 Purdue Pharma Latest Developments
13.3 Mallinckrodt
13.3.1 Mallinckrodt Company Information
13.3.2 Mallinckrodt Opioids Drug Product Portfolios and Specifications
13.3.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Mallinckrodt Main Business Overview
13.3.5 Mallinckrodt Latest Developments
13.4 Amneal Pharma
13.4.1 Amneal Pharma Company Information
13.4.2 Amneal Pharma Opioids Drug Product Portfolios and Specifications
13.4.3 Amneal Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Amneal Pharma Main Business Overview
13.4.5 Amneal Pharma Latest Developments
13.5 Collegium
13.5.1 Collegium Company Information
13.5.2 Collegium Opioids Drug Product Portfolios and Specifications
13.5.3 Collegium Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Collegium Main Business Overview
13.5.5 Collegium Latest Developments
13.6 J&J
13.6.1 J&J Company Information
13.6.2 J&J Opioids Drug Product Portfolios and Specifications
13.6.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 J&J Main Business Overview
13.6.5 J&J Latest Developments
13.7 Endo
13.7.1 Endo Company Information
13.7.2 Endo Opioids Drug Product Portfolios and Specifications
13.7.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Endo Main Business Overview
13.7.5 Endo Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Opioids Drug Product Portfolios and Specifications
13.8.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 INSYS
13.9.1 INSYS Company Information
13.9.2 INSYS Opioids Drug Product Portfolios and Specifications
13.9.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 INSYS Main Business Overview
13.9.5 INSYS Latest Developments
13.10 Mylan
13.10.1 Mylan Company Information
13.10.2 Mylan Opioids Drug Product Portfolios and Specifications
13.10.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Mylan Main Business Overview
13.10.5 Mylan Latest Developments
13.11 Hikma
13.11.1 Hikma Company Information
13.11.2 Hikma Opioids Drug Product Portfolios and Specifications
13.11.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hikma Main Business Overview
13.11.5 Hikma Latest Developments
13.12 Egalet
13.12.1 Egalet Company Information
13.12.2 Egalet Opioids Drug Product Portfolios and Specifications
13.12.3 Egalet Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Egalet Main Business Overview
13.12.5 Egalet Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Opioids Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Opioids Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oxycodone
Table 4. Major Players of Hydromorphone
Table 5. Major Players of Codeine
Table 6. Major Players of Fentanyl
Table 7. Global Opioids Drug Sales by Type (2020-2025) & (M Units)
Table 8. Global Opioids Drug Sales Market Share by Type (2020-2025)
Table 9. Global Opioids Drug Revenue by Type (2020-2025) & ($ million)
Table 10. Global Opioids Drug Revenue Market Share by Type (2020-2025)
Table 11. Global Opioids Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Opioids Drug Sale by Application (2020-2025) & (M Units)
Table 13. Global Opioids Drug Sale Market Share by Application (2020-2025)
Table 14. Global Opioids Drug Revenue by Application (2020-2025) & ($ million)
Table 15. Global Opioids Drug Revenue Market Share by Application (2020-2025)
Table 16. Global Opioids Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Opioids Drug Sales by Company (2020-2025) & (M Units)
Table 18. Global Opioids Drug Sales Market Share by Company (2020-2025)
Table 19. Global Opioids Drug Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Opioids Drug Revenue Market Share by Company (2020-2025)
Table 21. Global Opioids Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Opioids Drug Producing Area Distribution and Sales Area
Table 23. Players Opioids Drug Products Offered
Table 24. Opioids Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Opioids Drug Sales by Geographic Region (2020-2025) & (M Units)
Table 28. Global Opioids Drug Sales Market Share Geographic Region (2020-2025)
Table 29. Global Opioids Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Opioids Drug Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Opioids Drug Sales by Country/Region (2020-2025) & (M Units)
Table 32. Global Opioids Drug Sales Market Share by Country/Region (2020-2025)
Table 33. Global Opioids Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Opioids Drug Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Opioids Drug Sales by Country (2020-2025) & (M Units)
Table 36. Americas Opioids Drug Sales Market Share by Country (2020-2025)
Table 37. Americas Opioids Drug Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Opioids Drug Sales by Type (2020-2025) & (M Units)
Table 39. Americas Opioids Drug Sales by Application (2020-2025) & (M Units)
Table 40. APAC Opioids Drug Sales by Region (2020-2025) & (M Units)
Table 41. APAC Opioids Drug Sales Market Share by Region (2020-2025)
Table 42. APAC Opioids Drug Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Opioids Drug Sales by Type (2020-2025) & (M Units)
Table 44. APAC Opioids Drug Sales by Application (2020-2025) & (M Units)
Table 45. Europe Opioids Drug Sales by Country (2020-2025) & (M Units)
Table 46. Europe Opioids Drug Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Opioids Drug Sales by Type (2020-2025) & (M Units)
Table 48. Europe Opioids Drug Sales by Application (2020-2025) & (M Units)
Table 49. Middle East & Africa Opioids Drug Sales by Country (2020-2025) & (M Units)
Table 50. Middle East & Africa Opioids Drug Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Opioids Drug Sales by Type (2020-2025) & (M Units)
Table 52. Middle East & Africa Opioids Drug Sales by Application (2020-2025) & (M Units)
Table 53. Key Market Drivers & Growth Opportunities of Opioids Drug
Table 54. Key Market Challenges & Risks of Opioids Drug
Table 55. Key Industry Trends of Opioids Drug
Table 56. Opioids Drug Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Opioids Drug Distributors List
Table 59. Opioids Drug Customer List
Table 60. Global Opioids Drug Sales Forecast by Region (2026-2031) & (M Units)
Table 61. Global Opioids Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Opioids Drug Sales Forecast by Country (2026-2031) & (M Units)
Table 63. Americas Opioids Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Opioids Drug Sales Forecast by Region (2026-2031) & (M Units)
Table 65. APAC Opioids Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Opioids Drug Sales Forecast by Country (2026-2031) & (M Units)
Table 67. Europe Opioids Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Opioids Drug Sales Forecast by Country (2026-2031) & (M Units)
Table 69. Middle East & Africa Opioids Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Opioids Drug Sales Forecast by Type (2026-2031) & (M Units)
Table 71. Global Opioids Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Opioids Drug Sales Forecast by Application (2026-2031) & (M Units)
Table 73. Global Opioids Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Teva Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 75. Teva Opioids Drug Product Portfolios and Specifications
Table 76. Teva Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Teva Main Business
Table 78. Teva Latest Developments
Table 79. Purdue Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Purdue Pharma Opioids Drug Product Portfolios and Specifications
Table 81. Purdue Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Purdue Pharma Main Business
Table 83. Purdue Pharma Latest Developments
Table 84. Mallinckrodt Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Mallinckrodt Opioids Drug Product Portfolios and Specifications
Table 86. Mallinckrodt Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Mallinckrodt Main Business
Table 88. Mallinckrodt Latest Developments
Table 89. Amneal Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Amneal Pharma Opioids Drug Product Portfolios and Specifications
Table 91. Amneal Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Amneal Pharma Main Business
Table 93. Amneal Pharma Latest Developments
Table 94. Collegium Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Collegium Opioids Drug Product Portfolios and Specifications
Table 96. Collegium Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Collegium Main Business
Table 98. Collegium Latest Developments
Table 99. J&J Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. J&J Opioids Drug Product Portfolios and Specifications
Table 101. J&J Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. J&J Main Business
Table 103. J&J Latest Developments
Table 104. Endo Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Endo Opioids Drug Product Portfolios and Specifications
Table 106. Endo Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Endo Main Business
Table 108. Endo Latest Developments
Table 109. Pfizer Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Pfizer Opioids Drug Product Portfolios and Specifications
Table 111. Pfizer Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Pfizer Main Business
Table 113. Pfizer Latest Developments
Table 114. INSYS Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. INSYS Opioids Drug Product Portfolios and Specifications
Table 116. INSYS Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. INSYS Main Business
Table 118. INSYS Latest Developments
Table 119. Mylan Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Mylan Opioids Drug Product Portfolios and Specifications
Table 121. Mylan Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Mylan Main Business
Table 123. Mylan Latest Developments
Table 124. Hikma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Hikma Opioids Drug Product Portfolios and Specifications
Table 126. Hikma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Hikma Main Business
Table 128. Hikma Latest Developments
Table 129. Egalet Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. Egalet Opioids Drug Product Portfolios and Specifications
Table 131. Egalet Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Egalet Main Business
Table 133. Egalet Latest Developments
Table 1. Opioids Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Opioids Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oxycodone
Table 4. Major Players of Hydromorphone
Table 5. Major Players of Codeine
Table 6. Major Players of Fentanyl
Table 7. Global Opioids Drug Sales by Type (2020-2025) & (M Units)
Table 8. Global Opioids Drug Sales Market Share by Type (2020-2025)
Table 9. Global Opioids Drug Revenue by Type (2020-2025) & ($ million)
Table 10. Global Opioids Drug Revenue Market Share by Type (2020-2025)
Table 11. Global Opioids Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Opioids Drug Sale by Application (2020-2025) & (M Units)
Table 13. Global Opioids Drug Sale Market Share by Application (2020-2025)
Table 14. Global Opioids Drug Revenue by Application (2020-2025) & ($ million)
Table 15. Global Opioids Drug Revenue Market Share by Application (2020-2025)
Table 16. Global Opioids Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Opioids Drug Sales by Company (2020-2025) & (M Units)
Table 18. Global Opioids Drug Sales Market Share by Company (2020-2025)
Table 19. Global Opioids Drug Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Opioids Drug Revenue Market Share by Company (2020-2025)
Table 21. Global Opioids Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Opioids Drug Producing Area Distribution and Sales Area
Table 23. Players Opioids Drug Products Offered
Table 24. Opioids Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Opioids Drug Sales by Geographic Region (2020-2025) & (M Units)
Table 28. Global Opioids Drug Sales Market Share Geographic Region (2020-2025)
Table 29. Global Opioids Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Opioids Drug Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Opioids Drug Sales by Country/Region (2020-2025) & (M Units)
Table 32. Global Opioids Drug Sales Market Share by Country/Region (2020-2025)
Table 33. Global Opioids Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Opioids Drug Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Opioids Drug Sales by Country (2020-2025) & (M Units)
Table 36. Americas Opioids Drug Sales Market Share by Country (2020-2025)
Table 37. Americas Opioids Drug Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Opioids Drug Sales by Type (2020-2025) & (M Units)
Table 39. Americas Opioids Drug Sales by Application (2020-2025) & (M Units)
Table 40. APAC Opioids Drug Sales by Region (2020-2025) & (M Units)
Table 41. APAC Opioids Drug Sales Market Share by Region (2020-2025)
Table 42. APAC Opioids Drug Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Opioids Drug Sales by Type (2020-2025) & (M Units)
Table 44. APAC Opioids Drug Sales by Application (2020-2025) & (M Units)
Table 45. Europe Opioids Drug Sales by Country (2020-2025) & (M Units)
Table 46. Europe Opioids Drug Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Opioids Drug Sales by Type (2020-2025) & (M Units)
Table 48. Europe Opioids Drug Sales by Application (2020-2025) & (M Units)
Table 49. Middle East & Africa Opioids Drug Sales by Country (2020-2025) & (M Units)
Table 50. Middle East & Africa Opioids Drug Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Opioids Drug Sales by Type (2020-2025) & (M Units)
Table 52. Middle East & Africa Opioids Drug Sales by Application (2020-2025) & (M Units)
Table 53. Key Market Drivers & Growth Opportunities of Opioids Drug
Table 54. Key Market Challenges & Risks of Opioids Drug
Table 55. Key Industry Trends of Opioids Drug
Table 56. Opioids Drug Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Opioids Drug Distributors List
Table 59. Opioids Drug Customer List
Table 60. Global Opioids Drug Sales Forecast by Region (2026-2031) & (M Units)
Table 61. Global Opioids Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Opioids Drug Sales Forecast by Country (2026-2031) & (M Units)
Table 63. Americas Opioids Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Opioids Drug Sales Forecast by Region (2026-2031) & (M Units)
Table 65. APAC Opioids Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Opioids Drug Sales Forecast by Country (2026-2031) & (M Units)
Table 67. Europe Opioids Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Opioids Drug Sales Forecast by Country (2026-2031) & (M Units)
Table 69. Middle East & Africa Opioids Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Opioids Drug Sales Forecast by Type (2026-2031) & (M Units)
Table 71. Global Opioids Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Opioids Drug Sales Forecast by Application (2026-2031) & (M Units)
Table 73. Global Opioids Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Teva Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 75. Teva Opioids Drug Product Portfolios and Specifications
Table 76. Teva Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Teva Main Business
Table 78. Teva Latest Developments
Table 79. Purdue Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Purdue Pharma Opioids Drug Product Portfolios and Specifications
Table 81. Purdue Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Purdue Pharma Main Business
Table 83. Purdue Pharma Latest Developments
Table 84. Mallinckrodt Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Mallinckrodt Opioids Drug Product Portfolios and Specifications
Table 86. Mallinckrodt Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Mallinckrodt Main Business
Table 88. Mallinckrodt Latest Developments
Table 89. Amneal Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Amneal Pharma Opioids Drug Product Portfolios and Specifications
Table 91. Amneal Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Amneal Pharma Main Business
Table 93. Amneal Pharma Latest Developments
Table 94. Collegium Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Collegium Opioids Drug Product Portfolios and Specifications
Table 96. Collegium Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Collegium Main Business
Table 98. Collegium Latest Developments
Table 99. J&J Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. J&J Opioids Drug Product Portfolios and Specifications
Table 101. J&J Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. J&J Main Business
Table 103. J&J Latest Developments
Table 104. Endo Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Endo Opioids Drug Product Portfolios and Specifications
Table 106. Endo Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Endo Main Business
Table 108. Endo Latest Developments
Table 109. Pfizer Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Pfizer Opioids Drug Product Portfolios and Specifications
Table 111. Pfizer Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Pfizer Main Business
Table 113. Pfizer Latest Developments
Table 114. INSYS Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. INSYS Opioids Drug Product Portfolios and Specifications
Table 116. INSYS Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. INSYS Main Business
Table 118. INSYS Latest Developments
Table 119. Mylan Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Mylan Opioids Drug Product Portfolios and Specifications
Table 121. Mylan Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Mylan Main Business
Table 123. Mylan Latest Developments
Table 124. Hikma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Hikma Opioids Drug Product Portfolios and Specifications
Table 126. Hikma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Hikma Main Business
Table 128. Hikma Latest Developments
Table 129. Egalet Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. Egalet Opioids Drug Product Portfolios and Specifications
Table 131. Egalet Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Egalet Main Business
Table 133. Egalet Latest Developments
LIST OF FIGURES
Figure 1. Picture of Opioids Drug
Figure 2. Opioids Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioids Drug Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global Opioids Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Opioids Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Opioids Drug Sales Market Share by Country/Region (2024)
Figure 10. Opioids Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oxycodone
Figure 12. Product Picture of Hydromorphone
Figure 13. Product Picture of Codeine
Figure 14. Product Picture of Fentanyl
Figure 15. Global Opioids Drug Sales Market Share by Type in 2025
Figure 16. Global Opioids Drug Revenue Market Share by Type (2020-2025)
Figure 17. Opioids Drug Consumed in Pain Relief
Figure 18. Global Opioids Drug Market: Pain Relief (2020-2025) & (M Units)
Figure 19. Opioids Drug Consumed in Anesthesia
Figure 20. Global Opioids Drug Market: Anesthesia (2020-2025) & (M Units)
Figure 21. Opioids Drug Consumed in Others
Figure 22. Global Opioids Drug Market: Others (2020-2025) & (M Units)
Figure 23. Global Opioids Drug Sale Market Share by Application (2024)
Figure 24. Global Opioids Drug Revenue Market Share by Application in 2025
Figure 25. Opioids Drug Sales by Company in 2025 (M Units)
Figure 26. Global Opioids Drug Sales Market Share by Company in 2025
Figure 27. Opioids Drug Revenue by Company in 2025 ($ millions)
Figure 28. Global Opioids Drug Revenue Market Share by Company in 2025
Figure 29. Global Opioids Drug Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Opioids Drug Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Opioids Drug Sales 2020-2025 (M Units)
Figure 32. Americas Opioids Drug Revenue 2020-2025 ($ millions)
Figure 33. APAC Opioids Drug Sales 2020-2025 (M Units)
Figure 34. APAC Opioids Drug Revenue 2020-2025 ($ millions)
Figure 35. Europe Opioids Drug Sales 2020-2025 (M Units)
Figure 36. Europe Opioids Drug Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Opioids Drug Sales 2020-2025 (M Units)
Figure 38. Middle East & Africa Opioids Drug Revenue 2020-2025 ($ millions)
Figure 39. Americas Opioids Drug Sales Market Share by Country in 2025
Figure 40. Americas Opioids Drug Revenue Market Share by Country (2020-2025)
Figure 41. Americas Opioids Drug Sales Market Share by Type (2020-2025)
Figure 42. Americas Opioids Drug Sales Market Share by Application (2020-2025)
Figure 43. United States Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Opioids Drug Sales Market Share by Region in 2025
Figure 48. APAC Opioids Drug Revenue Market Share by Region (2020-2025)
Figure 49. APAC Opioids Drug Sales Market Share by Type (2020-2025)
Figure 50. APAC Opioids Drug Sales Market Share by Application (2020-2025)
Figure 51. China Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. India Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Opioids Drug Sales Market Share by Country in 2025
Figure 59. Europe Opioids Drug Revenue Market Share by Country (2020-2025)
Figure 60. Europe Opioids Drug Sales Market Share by Type (2020-2025)
Figure 61. Europe Opioids Drug Sales Market Share by Application (2020-2025)
Figure 62. Germany Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. France Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Opioids Drug Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Opioids Drug Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Opioids Drug Sales Market Share by Application (2020-2025)
Figure 70. Egypt Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Opioids Drug in 2025
Figure 76. Manufacturing Process Analysis of Opioids Drug
Figure 77. Industry Chain Structure of Opioids Drug
Figure 78. Channels of Distribution
Figure 79. Global Opioids Drug Sales Market Forecast by Region (2026-2031)
Figure 80. Global Opioids Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Opioids Drug Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Opioids Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Opioids Drug Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Opioids Drug Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Opioids Drug
Figure 2. Opioids Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioids Drug Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global Opioids Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Opioids Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Opioids Drug Sales Market Share by Country/Region (2024)
Figure 10. Opioids Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Oxycodone
Figure 12. Product Picture of Hydromorphone
Figure 13. Product Picture of Codeine
Figure 14. Product Picture of Fentanyl
Figure 15. Global Opioids Drug Sales Market Share by Type in 2025
Figure 16. Global Opioids Drug Revenue Market Share by Type (2020-2025)
Figure 17. Opioids Drug Consumed in Pain Relief
Figure 18. Global Opioids Drug Market: Pain Relief (2020-2025) & (M Units)
Figure 19. Opioids Drug Consumed in Anesthesia
Figure 20. Global Opioids Drug Market: Anesthesia (2020-2025) & (M Units)
Figure 21. Opioids Drug Consumed in Others
Figure 22. Global Opioids Drug Market: Others (2020-2025) & (M Units)
Figure 23. Global Opioids Drug Sale Market Share by Application (2024)
Figure 24. Global Opioids Drug Revenue Market Share by Application in 2025
Figure 25. Opioids Drug Sales by Company in 2025 (M Units)
Figure 26. Global Opioids Drug Sales Market Share by Company in 2025
Figure 27. Opioids Drug Revenue by Company in 2025 ($ millions)
Figure 28. Global Opioids Drug Revenue Market Share by Company in 2025
Figure 29. Global Opioids Drug Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Opioids Drug Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Opioids Drug Sales 2020-2025 (M Units)
Figure 32. Americas Opioids Drug Revenue 2020-2025 ($ millions)
Figure 33. APAC Opioids Drug Sales 2020-2025 (M Units)
Figure 34. APAC Opioids Drug Revenue 2020-2025 ($ millions)
Figure 35. Europe Opioids Drug Sales 2020-2025 (M Units)
Figure 36. Europe Opioids Drug Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Opioids Drug Sales 2020-2025 (M Units)
Figure 38. Middle East & Africa Opioids Drug Revenue 2020-2025 ($ millions)
Figure 39. Americas Opioids Drug Sales Market Share by Country in 2025
Figure 40. Americas Opioids Drug Revenue Market Share by Country (2020-2025)
Figure 41. Americas Opioids Drug Sales Market Share by Type (2020-2025)
Figure 42. Americas Opioids Drug Sales Market Share by Application (2020-2025)
Figure 43. United States Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Opioids Drug Sales Market Share by Region in 2025
Figure 48. APAC Opioids Drug Revenue Market Share by Region (2020-2025)
Figure 49. APAC Opioids Drug Sales Market Share by Type (2020-2025)
Figure 50. APAC Opioids Drug Sales Market Share by Application (2020-2025)
Figure 51. China Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. India Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Opioids Drug Sales Market Share by Country in 2025
Figure 59. Europe Opioids Drug Revenue Market Share by Country (2020-2025)
Figure 60. Europe Opioids Drug Sales Market Share by Type (2020-2025)
Figure 61. Europe Opioids Drug Sales Market Share by Application (2020-2025)
Figure 62. Germany Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. France Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Opioids Drug Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Opioids Drug Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Opioids Drug Sales Market Share by Application (2020-2025)
Figure 70. Egypt Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Opioids Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Opioids Drug in 2025
Figure 76. Manufacturing Process Analysis of Opioids Drug
Figure 77. Industry Chain Structure of Opioids Drug
Figure 78. Channels of Distribution
Figure 79. Global Opioids Drug Sales Market Forecast by Region (2026-2031)
Figure 80. Global Opioids Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Opioids Drug Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Opioids Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Opioids Drug Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Opioids Drug Revenue Market Share Forecast by Application (2026-2031)
